![Gerd Zettlmeissl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerd Zettlmeissl
Président chez
MEDIGENE AG
Profil
Gerd Zettlmeissl is currently Chairman-Supervisory Board at MediGene AG since 2019, Chairman at Valneva SE starting 2026, Chairman-Supervisory Board at MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. since 2013, Director at Aeras Global TB Vaccine Foundation since 2011, and Director at MinervaX ApS.
Former roles include Chairman-Management Board at Intercell AG from 2010 to 2011, Chairman at GlycoVaxyn AG from 2013 to 2015, Chairman at European Medical Solutions from 2017 to 2018, Chairman-Supervisory Board at Themis Bioscience GmbH from 2015 to 2020, Managing Director at Chiron Behring & Co., Director-Supervisory Board at Helmholtz-Zentrum für Infektionsforschung GmbH, and Head-Technical Operations at Chiron Corp.
Education includes a doctorate from the University of Regensburg.
Postes actifs de Gerd Zettlmeissl
| Sociétés | Poste | Début |
|---|---|---|
| MEDIGENE AG | Président | 22/05/2019 |
| VALNEVA SE | Président | 25/06/2026 |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 14/11/2011 |
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
 MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology Develops and researches vaccines | Président | 01/01/2013 |
Minervax ApS
 Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Directeur/Membre du Conseil | - |
Anciens postes connus de Gerd Zettlmeissl
| Sociétés | Poste | Fin |
|---|---|---|
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases | Président | 01/01/2020 |
| EUROPEAN MEDICAL SOLUTIONS | Président | 18/12/2018 |
GlycoVaxyn AG
 GlycoVaxyn AG BiotechnologyHealth Technology Developed and produced bioconjugate vaccines | Président | 01/01/2015 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Directeur Général | 10/05/2011 |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Gerd Zettlmeissl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Health Technology |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Chiron Behring & Co.
 Chiron Behring & Co. Medical DistributorsDistribution Services Supplies and developes new vaccine products for adults and children | Distribution Services |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoVaxyn AG
GlycoVaxyn AG BiotechnologyHealth Technology Developed and produced bioconjugate vaccines | Health Technology |
European Medical Solutions
 European Medical Solutions BiotechnologyHealth Technology Develops tools for diagnosis and treatment of immune response-related diseases | Health Technology |
Helmholtz-Zentrum für Infektionsforschung GmbH
 Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Provides infection biology research and development services | Health Technology |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases | Health Technology |
Minervax ApS
Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Health Technology |
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology Develops and researches vaccines | Health Technology |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
